低剂量CT肺癌筛查中的肺结节管理:NELSON试验的经验
本文综述荷兰-比利时NELSON试验在低剂量CT肺癌筛查中肺结节管理的关键发现,包括结节大小及体积评估、生长率、亚型与恶性风险,并与其它筛查研究及当前肺结节管理推荐进行比较,旨在为优化筛查项目中的肺结节管理提供参考。
要点
- NELSON试验采用基于结节体积评估和生长率的分流策略管理筛查检出的肺结节。
- 综述汇总了筛查检出结节的结节大小、体积评估、生长率、亚型及其相关恶性风险。
- 不同筛查研究采用不同的结节管理方案,本综述将NELSON结果与其它研究及当前推荐进行比较。
核心结论
- NELSON试验基于结节体积评估和生长率的分流策略为低剂量CT肺癌筛查中的肺结节管理提供了关键数据,本综述通过比较不同管理策略旨在为优化筛查项目中的肺结节管理提供参考。
研究设计与样本
- 综述类文章,围绕荷兰-比利时NELSON试验(欧洲最大的肺癌筛查试验)的筛查检出结节特征进行总结,并与其它筛查研究及当前肺结节管理推荐进行比较;原文未报告检索范围与纳入文献数量。
诊断标准与关键数值
- NELSON试验采用基于结节体积评估和生长率的分流策略来区分恶性与良性结节。
- 综述汇总了筛查检出结节的结节大小、体积评估、生长率、亚型及其相关恶性风险。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Screening with low-dose CT (LDCT) in a high-risk population, as defined by age and smoking behavior, reduces lung cancer-related mortality. However, LDCT screening presents a major challenge. Numerous, mostly benign, nodules are seen in the lungs during screening. The question is how to distinguish the malignant from the benign nodules. Various studies use different protocols for nodule management. The Dutch-Belgian NELSON (Nederlands-Leuvens Longkanker Screenings Onderzoek) trial, the largest European lung cancer screening trial, used distinctions based on nodule volumetric assessment and growth rate. This review discusses key findings from the NELSON study regarding the characteristics of screening-detected nodules, including nodule size and its volumetric assessment, growth rate, subtype, and their associated malignancy risk. These results are compared with findings from other screening studies and current recommendations for lung nodule management. By examining differences in nodule management strategies and providing a comprehensive overview of outcomes specific to lung cancer screening, this review aims to contribute to the broader discussion on optimizing lung nodule management in screening programs.
引用
- Zhong D, Sidorenkov G, Jacobs C, et al. Lung Nodule Management in Low-Dose CT Screening for Lung Cancer: Lessons from the NELSON Trial. Radiology. 2024. PMID: 39436294. doi:10.1148/radiol.240535
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。